611 W. Union Street
Benson, AZ 85602
(520) 586-0800

Health Choice Integrated Care crisis Line
1-877-756-4090

NurseWise 24-Hour Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

NurseWise 24-Hr Crisis Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Women's Health
Resources
Basic InformationLatest News
Early Onset of Pregnancy Complication May Raise Heart RisksUSPSTF Backs Cervical Cancer Screening With Cytology or hrHPVSurgeons Play Big Role in Women's Choices for Breast Cancer CareDoes Mother's Mental Health Affect Pregnancy?Hormone Therapy in Menopause Not Tied to Increased MortalityBeing Heard Key for Women After Gender-Based ViolenceWidening Waistlines May Raise Women's Cancer RiskHPV Test Alone OK for Cervical Cancer Screening Over 30: Expert PanelIs an Occasional Drink OK During Pregnancy?Could Hormone Supplements for Menopause Make a Comeback?Lidocaine Nerve Block Reduces Pain During IUD InsertionManaging Pain Can Be a Puzzle After Breast Cancer8 Ways College Women Can Protect Their HealthNumber of Women Seeing Obstetrician-Gynecologists DropsBreast-Feeding Linked to Lower Endometriosis RiskHPV Vaccine May Even Protect Women Who Never Got ItSleepless Nights Plague Many Women in Middle AgeHealth Tip: Suggestions for New MomsHigher Event Rate of T2DM in Polycystic Ovary SyndromeToo Many New Mothers Silent on Postpartum DepressionEstrogen Via Patch Superior for Menopausal Sexual SymptomsMany U.S. Women Unaware of Fibroid Treatments: PollFlame Retardants Associated With Reduced IVF SuccessWomen at Risk for Alzheimer's Face Critical 10-Year Window, Study SaysCould an Estrogen Patch Boost Women's Sex Lives in Menopause?Mortality Estimates Favor Annual Mammography From Age 40Outdoor Nighttime Light Exposure Linked to Breast Cancer RiskStudy Supports Annual Mammograms Starting at Age 40Oral Contraceptive Use Linked to Lower Rheumatoid Arthritis RiskCould Urban Lighting Raise Breast Cancer Risk for Some Women?High-Cal Foods May Raise Cancer Risk in Women, Even Without Weight GainEndometrial Ablation Doesn't Increase Cancer RiskHospital Volume, Quality Impact Survival in Ovarian CancerHistory of C-Section Ups Risk of Complications in HysterectomyStroke Rates Drop for U.S. Men, But Not WomenWomen Who Gain Weight Between Babies at Higher Risk for DiabetesBreast-Feeding Lowers Mom's Breast Cancer Risk: StudyGum Disease May Be Linked to Cancer Risk in Older Women'Super Moms' and 'Super Dads': Work-Home Conflicts Affect Both GendersEven a One-Minute Run Might Help a Woman's BonesLonger Estrogen Exposure May Protect Against DepressionMost Murdered U.S. Women Killed By Husbands, Boyfriends, ExesComplications Up With Immediate Reconstruction After MastectomyEstrogen May Influence Women's Depression RiskGood Diet, Exercise While Pregnant Could Cut C-section Risk'Nipple-Sparing' Mastectomies Don't Raise Odds of Cancer's Return: StudyEarly Menopause May Be Tied to Type 2 DiabetesMost Women Should Forgo Ovarian Cancer Screening: PanelWomen Driven to Be Thinner When Husband Is HotSmart Steps for Sun Protection
Questions and AnswersLinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Wellness and Personal Development
Mental Disorders

USPSTF Backs Cervical Cancer Screening With Cytology or hrHPV


HealthDay News
Updated: Sep 13th 2017

new article illustration

WEDNESDAY, Sept. 13, 2017 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends cervical cancer screening with cervical cytology alone every three years or screening with high-risk human papillomavirus (hrHPV) testing alone every five years in women ages 30 to 65 years. These findings form the basis of a draft recommendation statement published online Sept. 12 by the USPSTF.

Researchers from the USPSTF reviewed the benefits and harms of screening for cervical cancer using hrHPV testing as the screening strategy with or without cervical cytology in women aged 21 years or older.

For women aged 21 to 29 years, the USPSTF recommends screening for cervical cancer with cervical cytology alone every three years. For women aged 30 to 65 years, the USPSTF recommends screening every three years with cervical cytology alone or every five years with hrHPV testing alone (A recommendation). For women aged older than 65 years who have had adequate prior screening and are not considered at high risk for cervical cancer, for those without a cervix, and for women aged younger than 21 years, the USPSTF recommends against screening for cervical cancer (D recommendation). These findings form the basis of a draft recommendation statement, which is available for public comment from Sept. 12 through Oct. 9, 2017.

"Most cases of cervical cancer occur in women who have not been regularly screened or treated," USPSTF member Carol Mangione, M.D., M.S.P.H., said in a statement.

Evidence Review
Draft Recommendation Statement
Comment on Recommendation Statement